MedPath
NMPA Approval

Ofatumumab Injection

国药准字SJ20210034

December 20, 2021

Drug Information

奥法妥木单抗注射液

全欣达

注射剂

20mg(0.4mL)/支

生物制品

December 20, 2021

December 19, 2026

Company Information

Applicant Company

1 Health Plaza, East Hanover, NJ 07936 United States of America

Manufacturing Company

Schaffhauserstrasse, 4332 Stein, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥法妥木单抗注射液 - NMPA 批准文号 | MedPath